Fresh analysis suggests that people who come off new weight-loss injections like Mounjaro or Wegovy may regain reduced body mass at a significantly accelerated pace than those who halt conventional diet and exercise programs.
Findings released in a major medical journal points out that while obese people often shed substantial amounts of their body weight while undergoing treatment, the mass is regained at an estimated rate of 0.8 kg per month after stopping.
"People using these medications must be informed of the danger of fast rebound weight gain when the medication ends," stated researcher Dr. Susan Jebb.
Such speed of recovery means a reversion to pre-treatment mass in about one and a half years.
Analyzing Approaches
The analysis, which looked at dozens of studies involving thousands of participants, contrasted the outcomes of the injectable medications with older methods.
The team point out that people who shed pounds through diet and exercise usually have a less rapid creep back—approximately 100 grams monthly—after stopping.
Understanding the Fast Rebound
Nutrition scientists believe the way of the injections is key to understanding the amplified regain.
These medications copy a natural hormone called glucagon-like peptide-1, which moderates appetite.
"Artificially providing the hormone levels far above than normal might result in the system to produce less of its endogenous hormone, and may also lessen sensitivity to its actions," noted Dr. Adam Collins, a nutrition specialist.
"Discontinuation of this medication results in appetite is unsuppressed, making binge eating a significant risk."
A Lifelong Issue?
The NHS recommend the jabs for people with weight-linked health risks, accompanied by prescribed diet and exercise modifications.
Many experts contend that, considering the likelihood of weight regain, the therapy might need to be long-term.
This view is reinforced by pharmaceutical companies, who state that the findings "emphasize the long-term nature of obesity," comparing it to managing diseases like diabetes.
User Experiences
Individuals who have discontinued the jabs report a sudden return of hunger.
"It was like a switch activating and you become starving," described one woman.
The struggle is exacerbated if users have not adopted lasting lifestyle or habit modifications during therapy.
Significant Adoption
Figures indicate that millions of people in the UK have used weight-loss jabs in the past year, with desire continuing to grow.
- Use is more common among females than males.
- The middle-aged demographic shows the highest level of interest.
- A large proportion obtain the medications through private prescriptions rather than public health services.
In conclusion, researchers caution that while the jabs are effective agents for shedding pounds, they are not a permanent solution and lasting health benefits relies on ongoing lifestyle changes.
